Investor Contacts:
Arteris
Nick Hawkins
Chief Financial Officer
IR@arteris.com
Sapphire Investor Relations
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com
Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance for the first quarter and full year 2022 and our market opportunity and its potential growth, as well as our position within the market. Any forward-looking statements contained herein are based on our historical performance and our current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looks statements represent our expectations as of the date of this press release. Subsequent events may cause these expectations to change, and we disclaim any obligation to update the forward-looking statements in the future, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Important factors that could cause actual results to differ materially from those anticipated in our forward-looking statements include, but are not limited to, the significant competition we face from larger companies and third-party providers; our history of net losses; whether semiconductor companies in the automotive market, AI/ML market, 5G and wireless communications market, large scale cloud and data center market and consumer electronics market incorporate our solutions into their end products; our ability to attract new customers and the extent to which our customers renew their subscriptions for our solutions; the ability of our customers’ end products achieving market acceptance or growth; our ability to sustain or grow our licensing revenue; our ability, and the cost, to successfully execute on research and development efforts; the occurrence of product errors or defects in our solutions; if we fail to offer high-quality support; the occurrence of macro-economic conditions that adversely impact us, our customers and their end product markets; the range of regulatory, operational, financial and political risks we are exposed to as a result of our dependence on international customers and operations; our ability to protect our proprietary technology and inventions through patents and other IP rights; whether we are subject to any liabilities or fines as a result of government regulation, including import, export and economic sanctions laws and regulations; the occurrence of a disruption in our networks or a security breach; risks associated with doing business in China; and the other factors described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 to be filed with the Securities and Exchange Commission (SEC) on or about the date hereof and our subsequent filings with the SEC. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. Our results for the quarter ended December 31, 2021 are not necessarily indicative of our operating results for any future periods.
Arteris, Inc
Condensed Consolidated Statements of Loss and Comprehensive Loss
(in thousands, except share and per share data)
(Unaudited)
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||
| Revenue | |||||||||||||||
| Licensing, support and maintenance | $ | 10,378 | $ | 13,403 | $ | 34,731 | $ | 27,408 | |||||||
| Variable royalties and other | 1,056 | 1,043 | 3,133 | 4,404 | |||||||||||
| Total revenue | 11,434 | 14,446 | 37,864 | 31,812 | |||||||||||
| Cost of revenue | 1,113 | 373 | 3,731 | 1,491 | |||||||||||
| Gross profit | 10,321 | 14,073 | 34,133 | 30,321 | |||||||||||
| Operating expense: | |||||||||||||||
| Research and development | 10,240 | 5,178 | 30,812 | 17,020 | |||||||||||
| Sales and marketing | 3,755 | 3,404 | 11,726 | 9,749 | |||||||||||
| General and administrative | 3,606 | 2,336 | 13,360 | 7,329 | |||||||||||
| Total operating expenses | 17,601 | 10,918 | 55,898 | 34,098 | |||||||||||
| (Loss) income from operations | (7,280 | ) | 3,155 | (21,765 | ) | (3,777 | ) | ||||||||
| Gain on extinguishment of debt | — | 1,593 | 10 | 1,593 | |||||||||||
| Interest and other expense, net | (82 | ) | 61 | (589 | ) | (50 | ) | ||||||||
| (Loss) income before provision for income taxes | (7,362 | ) | 4,809 | (22,344 | ) | (2,234 | ) | ||||||||
| Provision (benefit) for income taxes | 428 | (2,767 | ) | 1,040 | 1,026 | ||||||||||
| Net (loss) income | (7,790 | ) | 7,576 | (23,384 | ) | (3,260 | ) | ||||||||
| Less: Net income attributable to participating securities | — | (1,520 | ) | — | — | ||||||||||
| Net (loss) income attributable to common stockholders | $ | (7,790 | ) | $ | 6,056 | $ | (23,384 | ) | $ | (3,260 | ) | ||||
| Net (loss) income per share attributable to common stockholders: | |||||||||||||||
| Basic | $ | (0.27 | ) | $ | 0.34 | $ | (1.06 | ) | $ | (0.19 | ) | ||||
| Diluted | $ | (0.27 | ) | $ | 0.29 | $ | (1.06 | ) | $ | (0.19 | ) | ||||
| Weighted average shares used on computing per share amounts: | |||||||||||||||
| Basic | 28,501,707 | 17,823,657 | 21,972,101 | 17,577,846 | |||||||||||
| Diluted | 28,501,707 | 20,546,017 | 21,972,101 | 17,577,846 | |||||||||||
